O4 Hubs detail
O4 Detail Hero Banner
O4 1 Column (Full)
O4 2 Columns (1/4 - 3/4)
O4 Text Component

Plan sponsors are considering different variations of separating specialty pharmacy from the pharmacy benefit manager (PBM). This may take the form of excluding certain drugs from the formulary, or even removing the specialty pharmacy function altogether. In this white paper, we address the four myths of these carve-out approaches and the impact they have:

  • Myth #1: Plan sponsors can better manage utilization with a specialty carve-out.
  • Myth #2: Patients receive equally good pharmacy care when specialty is carved out.
  • Myth #3: Specialty carve-out vendors offer a seamless patient experience with white-glove support.
  • Myth #4: Plan sponsors get better economic value with a specialty carve-out.
O4 Text Component

Learn how we can help solve your challenges

Related Content

O4 Complex Card

Drug pricing spotlight: Wound care

Combat against brand name products costing 125 times more.
O4 Complex Card

Rare diseases, large costs

The rise in orphan drugs is offering hope
O4 Complex Card

The personal side of specialty pharmacy

Care 'Cast videos highlight stories during the pandemic

Related Content

O4 Complex Card

How new medication packaging helps the planet

New packaging saves CO2, water, energy, and plastic waste.
O4 Complex Card

Reality check: New drugs will cost more

The trend toward complex biologic drugs continues

O4 Complex Card

Forum: Pharmacy care without compromise

Addressing pharmacy issues that matter